PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Ultra-LEAF™ Purified anti-human S100A8/A9 Heterodimer, 1 mg
Ultra-LEAF™ Purified anti-mouse Thrombopoietin (TPO), 1 mg
Ultra-LEAF™ Purified anti-mouse Thrombopoietin (TPO), 100 μg
Ultra-LEAF™ Purified anti-VEGF-121, 1 mg
Ultra-LEAF™ Purified anti-VEGF-121, 100 μg
Alexa Fluor® 488 anti-human CD223 (LAG-3), 100 tests
Alexa Fluor® 488 anti-human Granzyme A, 100 tests
Alexa Fluor® 488 anti-human IFN-γ, 100 tests
Alexa Fluor® 488 anti-human IFN-γ, 25 tests
Alexa Fluor® 488 anti-human IL-10, 100 tests
Alexa Fluor® 488 anti-human IL-10, 25 tests
Alexa Fluor® 488 anti-human IL-12/IL-23 p40, 100 tests
Alexa Fluor® 488 anti-human IL-17A, 100 tests
Alexa Fluor® 488 anti-human IL-17A, 25 tests
Alexa Fluor® 488 anti-human IL-17F, 100 tests
Alexa Fluor® 488 anti-human IL-17F, 25 tests